The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

South Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir, that research ...

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

GENEVA, (CMC)-The World Health Organization (WHO) on Monday advised countries, including those in the Caribbean to ensure ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

The Ghana HIV and AIDS Network (GHANET) is taking a proactive and strategic approach to combat the nation's HIV epidemic, focusing on a demographic often overlooked in health-seeking behaviours.

ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.

Despite some advancements in achieving key milestones towards ending AIDS in children and adolescents, progress remains slow ...

Aurobindo Pharma will manufacture and supply these injectable HIV treatment across 133 countries, including several low and ...